Understand the source comparison
GHRP-6 Acetate with Alcohol Safety: Research Comparison
Peak GH Amplitude (ng/mL) 18–25 7–12 5–9 Acute ethanol reduces pulse by 50–60%; chronic use compounds suppression Time to Peak GH (minutes) 20–30 35–50 40–60 Delayed hepatic response extends kinetic curve IGF-1 Synthesis (% baseline increase) 40–60% at 24 hour
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Peak GH Amplitude (ng/mL)
- 18–25
- 7–12
- 5–9
- Acute ethanol reduces pulse by 50–60%; chronic use compounds suppression
- Time to Peak GH (minutes)
- 20–30
- 35–50
- 40–60
- Delayed hepatic response extends kinetic curve
- IGF-1 Synthesis (% baseline increase)
- 40–60% at 24 hours
- 15–25% at 24 hours
- 10–18% at 24 hours
- Downstream anabolic signaling heavily attenuated with alcohol
- Hepatic NAD+ Depletion (%)
- 0% (baseline)
- 40–70% during metabolism
- 25–50% baseline chronic deficit
- NAD+ bottleneck is the primary mechanism of interference
- Hypothalamic GHRH Tone
- Normal baseline
- Suppressed 30–50% (GABAergic)
- Chronically blunted 20–40%
- GHRP-6 amplifies existing GHRH. If GHRH is low, response is blunted
- Recommended Abstinence Window
- N/A
- Minimum 8 hours; 12–16 hours optimal
- Exclude subjects with >5 drinks/week from protocols
- Timing alone insufficient if chronic use present